Mogamulizumab Biosimilar - Research Grade

Human

CCR4

5mg/ml

Human IgG1 Kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human CD194

Blue ice

C-C chemokine receptor 4 (CCR4) directs the trafficking of regulatory and Th2 T cells and is studied across oncology and inflammatory-disease research. Our anti-human CCR4 recombinant monoclonal is an unconjugated, non-therapeutic analog of mogamulizumab, released for research use only (RUO). Produced to in vivo standards, the low-endotoxin material is offered in scalable milligram (mg) to gram (g) quantities to support heavy-usage and high-throughput laboratories. It performs well in functional assays, chemotaxis and antibody-dependent cytotoxicity studies, control reagents, and in vivo models of T-cell trafficking and malignancy, providing the consistency required for reproducible immunology research.

CKR-4; CCR-4; CD194; K5-5

Q9UK39;Q9ULM6;P51679

ICH3002

https://www.imgt.org/mAb-DB/